Key result
Anemia in HF is linked to ~5-fold greater mortality, while iron sulfate improves LVEF.
Why the study?
Does iron sulfate improve ejection fraction and functional capacity in patients with chronic heart failure and iron deficiency anemia?
Cohort
Does iron sulfate improve ejection fraction and functional capacity in patients with chronic heart failure and iron deficiency anemia?
Answers are grounded in this paper and cite their sources.
Treating iron deficiency anemia with iron sulfate in patients with chronic heart failure is associated with improved ejection fraction and quality of life.
Objective: Approximately 30% of patients with Chronic Heart Failure (CHF) develop anemia. Previous studies showed the beneficial effect of treating the underlying anemia in CHF patients but controversy on the subject remains. We studied the prevalence and treatment of underlying anemia in patients with CHF. Methods and Results: Patients were categorized into three groups: normal hemoglobin levels, anemia of chronic disease; and iron deficiency anemia (IDA). All patients were treated for heart failure. Patients with IDA were treated with iron sulfate. We compared the ejection fractions (EF) and functional capacities both before and after treatment. The prevalence of IDA in our patients was 10.7% and 25.7% of patients had anemia of chronic disease. The mortality rate in the anemic group was 4.9 times higher than the mortality rate in the normal hemoglobin group. Following treatment, there was a significant increase in hemoglobin levels that was more prominent in the IDA group. EF increased in all groups following treatment, but the increase was greatest in the IDA group. Conclusions: Our results demonstrate the improved quality of life that results from treating IDA as part of CHF patient management. Early diagnosis and treatment of anemia can improve EF in patients with CHF.
No takes yet. Share an insight, caveat, or question.
Rafie et al. (2012) conducted a cohort in Chronic Heart Failure. Anemia and iron sulfate treatment vs. Normal hemoglobin levels was evaluated on Mortality and ejection fraction (4.9 times higher mortality). Anemia in chronic heart failure was associated with a 4.9 times higher mortality rate compared to normal hemoglobin, while iron sulfate treatment for iron deficiency improved ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: